Among complement regulatory proteins, urinary abundance of complement factor H (CFAH) was significantly higher, whereas complement factor I (CFAI), decay-accelerating factor (DAF, also known as CD55), CD59, and clusterin (CLUS) were significantly lower in patients with T2DM and DN compared with HC participants or patients with T2DM. This evidence concerns the gene CD59 and type 2 diabetes mellitus.